These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26423648)

  • 1. HIV viral load messages should go viral in India.
    Isaakidis P; Gupta S; Das M; Ferrer D; Nalinikanta R; Reid T; Horn T; Frick M
    Lancet HIV; 2015 Oct; 2(10):e414-5. PubMed ID: 26423648
    [No Abstract]   [Full Text] [Related]  

  • 2. Beyond first-line HIV treatment regimens: the current state of antiretroviral regimens, viral load monitoring, and resistance testing in resource-limited settings.
    Kumarasamy N; Krishnan S
    Curr Opin HIV AIDS; 2013 Nov; 8(6):586-90. PubMed ID: 24100872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public health. Getting HIV treatment to the most people.
    Lynch S; Ford N; van Cutsem G; Bygrave H; Janssens B; Decroo T; Andrieux-Meyer I; Roberts T; Balkan S; Casas E; Ferreyra C; Bemelmans M; Cohn J; Kahn P; Goemaere E
    Science; 2012 Jul; 337(6092):298-300. PubMed ID: 22798404
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV viral load scale-up: multiple interventions to meet the HIV treatment cascade.
    Carmona S; Peter T; Berrie L
    Curr Opin HIV AIDS; 2017 Mar; 12(2):157-164. PubMed ID: 28134713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DART points the way for HIV treatment programmes.
    Phillips A; van Oosterhout J
    Lancet; 2010 Jan; 375(9709):96-8. PubMed ID: 20004465
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness of first-line antiretroviral therapy and acquired drug resistance among HIV-1-infected children in India.
    Shet A; Neogi U; Sahoo PN; De Costa A
    Pediatr Infect Dis J; 2013 May; 32(5):e227-9. PubMed ID: 23249907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the significance of posttreatment control of HIV infection vis-à-vis functional cure?
    Vanham G; Buvé A; Florence E; Seguin-Devaux C; Sáez-Cirión A
    AIDS; 2014 Feb; 28(4):603-5. PubMed ID: 24401643
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings.
    Phillips AN; Pillay D; Garnett G; Bennett D; Vitoria M; Cambiano V; Lundgren J
    AIDS; 2011 Mar; 25(6):843-50. PubMed ID: 21192233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model for reduced HIV-1 viral load monitoring in resource-limited settings.
    Bryant L; Smith N; Keiser P
    J Int Assoc Provid AIDS Care; 2013; 12(1):67-71. PubMed ID: 22553318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achieving a quantitative understanding of antiretroviral drug efficacy.
    Shen L; Siliciano RF
    Clin Infect Dis; 2010 Nov; 51(9):1105-6; author reply 1106-7. PubMed ID: 20925507
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV in 2010: potent antiretroviral drugs treat and sensitive assays monitor the infection; but there remain outstanding issues.
    Antonelli G
    Clin Microbiol Infect; 2010 Oct; 16(10):1509-10. PubMed ID: 20854461
    [No Abstract]   [Full Text] [Related]  

  • 12. Improving laboratory efficiencies to scale-up HIV viral load testing.
    Alemnji G; Onyebujoh P; Nkengasong JN
    Curr Opin HIV AIDS; 2017 Mar; 12(2):165-170. PubMed ID: 28059956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Illustration of a measure to combine viral suppression and viral rebound in studies of HIV therapy.
    Edwards JK; Cole SR; Adimora A; Fine J; Martin J; Eron J
    J Acquir Immune Defic Syndr; 2015 Feb; 68(2):241-4. PubMed ID: 25415292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconsidering early HIV treatment and supervised treatment interruptions.
    Koup RA
    PLoS Med; 2004 Nov; 1(2):e41. PubMed ID: 15578109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the effectiveness of antiretroviral treatment among HIV-infected adults: a prospective cohort study in Yunnan Province, 2004-2010.
    Lu L; Ma W; Jia M; Wang L; Guo W; Peng Z; Yu R; Wang N
    AIDS Res Hum Retroviruses; 2015 Feb; 31(2):161-2. PubMed ID: 25400262
    [No Abstract]   [Full Text] [Related]  

  • 16. [Utility of the viral load measurement after one month of antiretroviral treatment].
    Kra O; Ouattara B; Aba Y; Roger P; Dellamonica P
    Sante; 2010; 20(3):149-52. PubMed ID: 21126946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Futility of CD4+ monitoring in HIV-1 patients with CD4+ cell count above 350 cells/μl on suppressive antiretroviral therapy.
    Duncan CJ; Schmid ML; Schwab U; Price DA; Ong E
    AIDS; 2014 Nov; 28(17):2638-9. PubMed ID: 25418545
    [No Abstract]   [Full Text] [Related]  

  • 18. 3rd International AIDS Society Conference.
    Das P
    Lancet Infect Dis; 2005 Sep; 5(9):541. PubMed ID: 16156006
    [No Abstract]   [Full Text] [Related]  

  • 19. Post-treatment control in an adult with perinatally acquired HIV following cessation of antiretroviral therapy.
    McMahon JH; Chang J; Tennakoon S; Dantanarayana A; Solomon A; Cherry C; Doherty R; Cameron P; Lewin SR
    AIDS; 2017 Jun; 31(9):1344-1346. PubMed ID: 28492397
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of treatment simplification on HIV reservoirs.
    Darcis G; Moutschen M
    Lancet HIV; 2017 Aug; 4(8):e328-e329. PubMed ID: 28750742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.